Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT02030054
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT02030054
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT02030054. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)
- Acronym
- gRANADa
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct02030054- Content hash
3905fac2958b757469169501ed6b040c9fe02505c40aef1bf390d43f0b05f4ad